Two of the world’s top pharmaceutical manufacturers, Novartis and GlaxoSmithKline (GSK), have signed a multi-billion-dollar deal to join and restructure their businesses.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.